BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Augello G, Emma MR, Cusimano A, Azzolina A, Mongiovì S, Puleio R, Cassata G, Gulino A, Belmonte B, Gramignoli R, Strom SC, Mccubrey JA, Montalto G, Cervello M. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma. Int J Cancer 2019;144:2613-24. [DOI: 10.1002/ijc.31963] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Liu R. Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma. Heliyon 2022;8:e10612. [PMID: 36158075 DOI: 10.1016/j.heliyon.2022.e10612] [Reference Citation Analysis]
2 Kamal MA, Mandour YM, Abd El-aziz MK, Stein U, El Tayebi HM. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. Molecules 2022;27:5537. [DOI: 10.3390/molecules27175537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Li L, Yu S, Chen J, Quan M, Gao Y, Li Y. miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-01094-2] [Reference Citation Analysis]
4 Shen LJ, Sun HW, Chai YY, Jiang QY, Zhang J, Li WM, Xin SJ. The Disassociation of the A20/HSP90 Complex via Downregulation of HSP90 Restores the Effect of A20 Enhancing the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents. Front Oncol 2021;11:804412. [PMID: 34976842 DOI: 10.3389/fonc.2021.804412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gao B, Wang L, Zhang N, Han M, Zhang Y, Liu H, Sun D, Liu Y. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database. Kidney Blood Press Res 2021;46:702-13. [PMID: 34818247 DOI: 10.1159/000518437] [Reference Citation Analysis]
6 Molavipordanjani S, Hosseinimehr SJ. The Radiolabeled HER3 Targeting Molecules for Tumor Imaging. Iran J Pharm Res 2021;20:141-52. [PMID: 34400948 DOI: 10.22037/ijpr.2021.114677.14991] [Reference Citation Analysis]
7 Augello G, Emma MR, Azzolina A, Puleio R, Condorelli L, Cusimano A, Giannitrapani L, McCubrey JA, Iovanna JL, Cervello M. The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma. Cancer Lett 2021;519:250-62. [PMID: 34314755 DOI: 10.1016/j.canlet.2021.07.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Epp-Ducharme B, Dunne M, Fan L, Evans JC, Ahmed L, Bannigan P, Allen C. Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro. Sci Rep 2021;11:11103. [PMID: 34045581 DOI: 10.1038/s41598-021-90585-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mansour SMA, Ali SA, Nofal S, Soror SH. Targeting NUPR1 for Cancer Treatment: A Risky Endeavor. Curr Cancer Drug Targets 2020;20:768-78. [PMID: 32619170 DOI: 10.2174/1568009620666200703152523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Li A, Chen X, Jing Z, Chen J. Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma. FEBS Open Bio 2020;10:2097-106. [PMID: 32810364 DOI: 10.1002/2211-5463.12960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhang X, Zhang P, An L, Sun N, Peng L, Tang W, Ma D, Chen J. Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta Pharm Sin B 2020;10:1397-413. [PMID: 32963939 DOI: 10.1016/j.apsb.2020.06.015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 30.0] [Reference Citation Analysis]
12 Nouri-Vaskeh M, Alizadeh L, Hajiasgharzadeh K, Mokhtarzadeh A, Halimi M, Baradaran B. The role of HSP90 molecular chaperones in hepatocellular carcinoma. J Cell Physiol 2020;235:9110-20. [PMID: 32452023 DOI: 10.1002/jcp.29776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Lan W, Santofimia-Castaño P, Xia Y, Zhou Z, Huang C, Fraunhoffer N, Barea D, Cervello M, Giannitrapani L, Montalto G, Peng L, Iovanna J. Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma. Cancer Lett 2020;486:8-17. [PMID: 32446862 DOI: 10.1016/j.canlet.2020.04.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
14 Thanner J, Bekos C, Veraar C, Janik S, Laggner M, Boehm PM, Schiefer AI, Müllauer L, Klepetko W, Ankersmit HJ, Moser B. Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis. Oncoimmunology 2020;9:1756130. [PMID: 32923112 DOI: 10.1080/2162402X.2020.1756130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Chang X, Zhang M, Wang C, Zhang J, Wu H, Yang S. Graphene oxide / BaHoF5 / PEG nanocomposite for dual-modal imaging and heat shock protein inhibitor-sensitized tumor photothermal therapy. Carbon 2020;158:372-85. [DOI: 10.1016/j.carbon.2019.10.105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
16 Jiang Q, Shen X. Research Progress of Heat Shock Protein 90 and Hepatocellular Carcinoma. IJCM 2020;11:43-52. [DOI: 10.4236/ijcm.2020.112005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tutar L, Yenilmez Tunoglu EN, Yeman Kiyak B, Tutar Y. Heat Shock Protein and Cancer Based Therapies. Heat Shock Proteins 2020. [DOI: 10.1007/7515_2020_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chai Z, Wang L, Zheng Y, Liang N, Wang X, Zheng Y, Zhang Z, Zhao C, Zhu T, Liu C. PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer. Cancer Cell Int 2019;19:277. [PMID: 31708688 DOI: 10.1186/s12935-019-0999-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Huang DH, Jian J, Li S, Zhang Y, Liu LZ. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway. Int J Mol Med 2019;44:2113-22. [PMID: 31638175 DOI: 10.3892/ijmm.2019.4371] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
20 Feng J, Wu L, Ji J, Chen K, Yu Q, Zhang J, Chen J, Mao Y, Wang F, Dai W, Xu L, Wu J, Guo C. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma. J Exp Clin Cancer Res 2019;38:204. [PMID: 31101057 DOI: 10.1186/s13046-019-1194-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
21 Zhang Y, Xiao Y, Dong Q, Ouyang W, Qin Q. Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro. J Food Sci 2019;84:904-10. [PMID: 30866043 DOI: 10.1111/1750-3841.14484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
22 Dong X, Wang F, Xue Y, Lin Z, Song W, Yang N, Li Q. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Int J Mol Med 2019;43:1417-29. [PMID: 30664155 DOI: 10.3892/ijmm.2019.4062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]